ANDAORALCAPSULE
Approved
Sep 2012
Lifecycle
Post-LOE
Competitive Pressure
30/100
Clinical Trials
20
Clinical Trials (5)
Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation
Started Jun 2026
124 enrolled
LeukemiaMyelodysplasiaChronic Myelomonocytic Leukemia
A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation
Started Mar 2026
526 enrolled
Kidney Transplant Rejection
Neurocognitive Function Changes With Extended-Release Tacrolimus Among Older Kidney Transplant Recipients
Started Dec 2025
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
Started Apr 2025
572 enrolled
Graft-versus-host Disease (GVHD)
Early Use of Long-acting Tacrolimus in Lung Transplant Recipients
Started Dec 2023